Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

Haller, Hermann; Ito, Sadayoshi; L. Izzo, Joseph; Januszewicz, Andrzej; Katayama, Shigehiro; Menne, Jan; Mimran, A; J. Rabelink, Ton; Ritz, Eberhard; M. Ruilope, Luís; Christian Rump, Lars; Viberti, Giancarlo

doi:10.1056/nejmoa1007994

Public

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

Published in New England Journal of Medicine • Mar 9, 2011

Authors:

Hermann Haller

Sadayoshi Ito

Joseph L. Izzo

Abstract

BACKGROUND: Microalbuminuria is an early predictor of diabetic nephropathy and premature cardiovascular disease. We investigated whether treatment with an angiotensin-receptor blocker (ARB) would delay or prevent the occurrence of microalbuminuria in patients with type 2 diabetes and normoalbuminuri...

Subject

Microalbuminuria

Olmesartan

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!